Randomized, controlled crossover study of IVIg for demyelinating polyneuropathy and diabetes
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received February 13, 2019
- Accepted in final form May 28, 2019
- First Published July 10, 2019.
Author Disclosures
- Ari Breiner, MD, MSc, FRCPC,
- Carolina Barnett Tapia, MD, PhD,
- Leif Erik Lovblom, MSc,
- Bruce A. Perkins, MD, MPH, FRCPC,
- Hans D. Katzberg, MD, MSc, FRCPC and
- Vera Bril, MD, FRCPC
- Ari Breiner, MD, MSc, FRCPC,
(1) Pfizer (2) Akcea
NONE
(1) CSL Behring (2) Allergan
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) Grifols, Inc.
NONE
NONE
(1) GBS-CIDP International Foundation (2) Muscular Dystrophy Canada
NONE
NONE
NONE
NONE
NONE
NONE
- Carolina Barnett Tapia, MD, PhD,
Canadian Advisory board for Alexion
NONE
NONE
NONE
NONE
NONE
NONE
(1) Alexion (2)Akcea (3) Grifols (4) Takeda
NONE
NONE
NONE
(1) Research grant from Octapharma, for clinician-initiated research (2) research grant from Grfiols for clinician-initiated research
(1) US Department of Defense. Neurofibromatosis program, new investigator award. Role: PI, year: 2019-2022 (2) NIH. PAR-17-184. Role: Co-investigator. 2018-2023
(1) New initiatives grant. University of Toronto, Division of Neurology
(1) Muscular Dystrophy Canada. Seed Grant. Role; co-investigator. 2019-2020
NONE
NONE
(1) May receive future royalties for licensing of the MGII
NONE
NONE
NONE
- Leif Erik Lovblom, MSc,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Bruce A. Perkins, MD, MPH, FRCPC,
1. Advisor for Boehringer Ingelheim (Commercial entity) 2. Advisor for Abbott (Comercial Entity)
NONE
Honoraria for continuing medical education events from Abbott (Commercial entity), Medtronic (Commercial entity), Boehringer Ingelheim (Commercial entity), Janssen (Commercial entity), Insulet (Commercial entity), Janssen (Commercial entity)
Diabetes Care, Editorial board
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Operating funds were paid to my research institution by Boehringer Ingelheim (Commercial entity) and Bank of Montreal (Commercial Entity) for work that I am the local principal investigator on.
1) NIH/NIDDK 2) Canadian Institutes for Health Research
NONE
1) JDRF 2) Diabetes Canada
NONE
NONE
NONE
NONE
NONE
NONE
- Hans D. Katzberg, MD, MSc, FRCPC and
Data safety monitoring board for Octapharma clinical study.
NONE
1) Genzyme Canada - funding for air, hotel to Steps Forward Meeting Berlin, Germany ∼4K 2) Speaker honoraria from CSL Behring, Grifols, Genzyme, Akcea, Terumo
Associate Editor CJNS 2014-2019.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
1) CSL Behring - investigator initiated grant on SCIG for MMN
NONE
1) University of Toronto Division of neurology - New Initiative Grant for assessment of sleep in MG
1) Myasthenia Gravis Foundation of America - research grant on PET labeling for MG
NONE
NONE
NONE
NONE
NONE
NONE
- Vera Bril, MD, FRCPC
(1) CSL Behring (2) Argenyx (3) UCB
NONE
(1) CSL Behring
(1) PLoS One, editorial board member starting 2016
NONE
NONE
NONE
(1) Alnylam (2) Alexion (3) Akcea (4) Pfizer (5) CSL Behring (6) Grifols (7) Octapharma (8) Powell Mansfield Inc, (9) Argenyx (10) UCB (11) Immunovant (12) Takeda (Shire)
NONE
NONE
NONE
(1) CSL Behring (2) Baxalta (3) Grifols (4) Argenyx (5) Octapharma (6) Takeda (Shire) (7) UCB
NONE
NONE
(1) Toronto General/Toronto Western Hospital Foundation (2) GBS/CIDP Foundation International
NONE
NONE
NONE
NONE
NONE
NONE
- From the Division of Neurology (A.B.), Department of Medicine, the Ottawa Hospital; Ottawa Hospital Research Institute (A.B.); Division of Neurology (C.B., H.D.K., V.B.), Department of Medicine, Ellen and Martin Prosserman Centre for Neuromuscular Diseases, University Health Network, University of Toronto; Division of Endocrinology and Metabolism (L.E.L., B.A.P.), Department of Medicine, Mount Sinai, Hospital and Lunenfeld Tanenbaum Research Institute, University of Toronto, Canada; and Institute for Research and Medical Consultations (V.B.), Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
- Correspondence
Dr. Breiner abreiner{at}toh.ca
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Nicole Sur and Dr. Mausaminben Hathidara
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Article
Long-term safety and efficacy of subcutaneous immunoglobulin IgPro20 in CIDPPATH extension studyIvo N. van Schaik, Orell Mielke, Vera Bril et al.Neurology: Neuroimmunology & Neuroinflammation, July 03, 2019 -
Article
Residual fatigue in Guillain-Barré syndrome is related to axonal lossJudith Drenthen, Bart C. Jacobs, Ellen M. Maathuis et al.Neurology, October 25, 2013 -
Brief Communications
Distinguishing acute-onset CIDP from Guillain–Barré syndrome with treatment related fluctuationsLiselotte Ruts, Rinske van Koningsveld, Pieter A. van Doorn et al.Neurology, July 11, 2005 -
Article
Paraparetic Guillain-Barré syndromeBianca van den Berg, Christiaan Fokke, Judith Drenthen et al.Neurology, May 07, 2014